David A. Ahlquist

16.1k total citations · 1 hit paper
231 papers, 11.2k citations indexed

About

David A. Ahlquist is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, David A. Ahlquist has authored 231 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Oncology, 82 papers in Pathology and Forensic Medicine and 76 papers in Surgery. Recurrent topics in David A. Ahlquist's work include Colorectal Cancer Screening and Detection (102 papers), Genetic factors in colorectal cancer (78 papers) and Gastric Cancer Management and Outcomes (60 papers). David A. Ahlquist is often cited by papers focused on Colorectal Cancer Screening and Detection (102 papers), Genetic factors in colorectal cancer (78 papers) and Gastric Cancer Management and Outcomes (60 papers). David A. Ahlquist collaborates with scholars based in United States, Vietnam and Germany. David A. Ahlquist's co-authors include Barry M. Berger, C. Daniel Johnson, Graham P. Lidgard, Douglas W. Mahoney, Jonathan J. Harrington, Theodore R. Levin, William S. Harmsen, Steven H. Itzkowitz, John B. Kisiel and Thomas F. Imperiale and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

David A. Ahlquist

229 papers receiving 10.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multitarget Stool DNA Testing for Colorectal-Cancer Screening

2014 1.3k citations Theodore R. Levin, Graham P. Lidgard et al. profile →

Peers

Countries citing papers authored by David A. Ahlquist

Since Specialization

Citations

This map shows the geographic impact of David A. Ahlquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Ahlquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Ahlquist more than expected).

Fields of papers citing papers by David A. Ahlquist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Ahlquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Ahlquist. The network helps show where David A. Ahlquist may publish in the future.

Co-authorship network of co-authors of David A. Ahlquist

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Ahlquist. A scholar is included among the top collaborators of David A. Ahlquist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Ahlquist. David A. Ahlquist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9 2021 ·Clinical Cancer Research ·Shounak Majumder, William R. Taylor, Patrick H. Foote, Calise K. Berger, Chung Wah Wu, Douglas W. Mahoney, William R. Bamlet, Kelli N. Burger, (unknown), (unknown), (unknown), Graham P. Lidgard, Hatim T. Allawi, Gloria M. Petersen, Suresh T. Chari, David A. Ahlquist, John B. Kisiel	34
2	Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence 2020 ·Clinical Cancer Research ·Hao Xie, Douglas W. Mahoney, Patrick H. Foote, Kelli N. Burger, (unknown), William R. Taylor, (unknown), Xiaoming Cao, (unknown), Calise K. Berger, Tsung‐Teh Wu, Joleen M. Hubbard, Hatim T. Allawi, Michael W. Kaiser, Graham P. Lidgard, David A. Ahlquist, John B. Kisiel	20
3	Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma 2019 ·Clinical Cancer Research ·Yi Qin, Chung Wah Wu, William R. Taylor, Tarek Sawas, Kelli N. Burger, Douglas W. Mahoney, Zhifu Sun, Tracy C. Yab, Graham P. Lidgard, Hatim T. Allawi, Navtej Buttar, Thomas C. Smyrk, Prasad G. Iyer, David A. Katzka, David A. Ahlquist, John B. Kisiel	40
4	Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma 2018 ·Clinical Cancer Research ·(unknown), Yun‐Suhk Suh, Boram Choi, Hyuk‐Joon Lee, Tracy C. Yab, William R. Taylor, Brian A. Dukek, Calise K. Berger, (unknown), Patrick H. Foote, Mary E. Devens, Lisa A. Boardman, John B. Kisiel, Douglas W. Mahoney, Seth W. Slettedahl, Hatim T. Allawi, Graham P. Lidgard, Thomas C. Smyrk, Han‐Kwang Yang, David A. Ahlquist	47
5	Jaktforsøk på brunbjørn med hund - antall og hundetypens betydning for bjørnens fysiologi 2018 ·Duo Research Archive (University of Oslo) ·Ole‐Gunnar Støen, (unknown), (unknown), Solve Sæbø, Geir Rune Rauset, Jon M. Arnemo, Boris Fuchs, Alina L. Evans, David A. Ahlquist, (unknown)	1
6	Shifts in the Fecal Microbiota Associated with Adenomatous Polyps 2016 ·Cancer Epidemiology Biomarkers & Prevention ·Vanessa L. Hale, Jun Chen, Stephen Johnson, Sean C. Harrington, Tracy C. Yab, Thomas C. Smyrk, Heidi Nelson, Lisa A. Boardman, Brooke R. Druliner, Theodore R. Levin, Douglas K. Rex, Dennis J. Ahnen, Peter Lance, David A. Ahlquist, Nicholas Chia	149
7	Long-term Follow-up of Patients Having False-Positive Multitarget Stool DNA Tests after Negative Screening Colonoscopy: The LONG-HAUL Cohort Study 2016 ·Cancer Epidemiology Biomarkers & Prevention ·Thomas G. Cotter, Kelli N. Burger, Mary E. Devens, Julie A. Simonson, (unknown), Russell I. Heigh, Douglas W. Mahoney, David H. Johnson, David A. Ahlquist, John B. Kisiel	24
8	Multi-Target Stool DNA Test: Is the Future Here? 2016 ·Current Gastroenterology Reports ·Seth Sweetser, David A. Ahlquist	2
9	New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice 2015 ·Clinical Cancer Research ·John B. Kisiel, Massimo Raimondo, William R. Taylor, Tracy C. Yab, Douglas W. Mahoney, Zhifu Sun, Sumit Middha, Saurabh Baheti, Hongzhi Zou, Thomas C. Smyrk, Lisa A. Boardman, Gloria M. Petersen, David A. Ahlquist	92
10	Molecular markers for colorectal cancer screening 2015 ·Gut ·(unknown), John B. Kisiel, David A. Ahlquist, William M. Grady	102
11	Next-Generation Stool DNA Test Accurately Detects Colorectal Cancer and Large Adenomas 2011 ·Gastroenterology ·David A. Ahlquist, Hongzhi Zou, Michael J. Domanico, Douglas W. Mahoney, Tracy C. Yab, William R. Taylor, Malinda L. Butz, Stephen N. Thibodeau, Linda Rabeneck, Lawrence Paszat, Kenneth W. Kinzler, Bert Vogelstein, (unknown), Søren Laurberg, Henrik Toft Sørensen, Barry M. Berger, Graham P. Lidgard	233
12	Recurrent Cervical Carcinoma Mimicking Rectal Cancer 2010 ·Clinical Gastroenterology and Hepatology ·Seth Sweetser, David A. Ahlquist	2
13	Identification and Validation of Colorectal Neoplasia–Specific Methylation Markers for Accurate Classification of Disease 2007 ·Molecular Cancer Research ·Fabian Model, Neal Osborn, David A. Ahlquist, (unknown), Béla Molnár, Ferenc Sípos, Orsolya Galamb, Christian Pilarsky, (unknown), Zsolt Tulassay, Kari Hale, Suzanne Mooney, (unknown), Péter Adorján, Ralf Lesche, (unknown), (unknown), (unknown), Andrew Sledziewski, Catherine Lofton–Day	45
14	CT colonography: unraveling the twists and turns. 2005 ·PubMed ·Joel G. Fletcher, Fargol Booya, C. Daniel Johnson, David A. Ahlquist	21
15	Comparison of the relative sensitivity of CT colonography and double-contrast barium enema for screen detection of colorectal polyps 2004 ·Clinical Gastroenterology and Hepatology ·C. Daniel Johnson, Robert L. MacCarty, Timothy J. Welch, Lynn A. Wilson, William S. Harmsen, Duane M. Ilstrup, David A. Ahlquist	55
16	Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis 2000 ·Gastroenterology ·Patrick S. Kamath, Marco A. Lacerda, David A. Ahlquist, (unknown), James C. Andrews, (unknown)	130
17	Fecal Occult Blood Testing for Iron Deficiency: A Reappraisal 2000 ·Digestive Diseases ·Gavin C. Harewood, David A. Ahlquist	9
18	Computed tomography colonography (virtual colonoscopy): a new method for colorectal screening 1999 ·Gut ·C. Daniel Johnson, David A. Ahlquist	28
19	Association of primary sclerosing cholangitis and colorectal cancer in patients with ulcerative colitis: Is it true and does it matter? 1998 ·Gastroenterology ·William J. Sandborn, Edward V. Loftus, David A. Ahlquist	11
20	Does performance status influence the outcome of Nd:YAG laser therapy of proximal esophageal tumors? 1994 ·Gastrointestinal Endoscopy ·Glenn L. Alexander, Kenneth K. Wang, David A. Ahlquist, Thomas R. Viggiano, Christopher J. Gostout, Rita K. Balm	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact